US 10442788
Hepatitis B antiviral agents
granted A61KA61K31/4164A61K31/4178
Quick answer
US patent 10442788 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4164, A61K31/4178, A61K31/454, A61K31/496